Qiang Zou

1.6k total citations
56 papers, 1.2k citations indexed

About

Qiang Zou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qiang Zou has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 16 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Qiang Zou's work include RNA modifications and cancer (7 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer-related molecular mechanisms research (5 papers). Qiang Zou is often cited by papers focused on RNA modifications and cancer (7 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer-related molecular mechanisms research (5 papers). Qiang Zou collaborates with scholars based in China, United States and Taiwan. Qiang Zou's co-authors include Yiting Jin, Xiuping Liu, Chengyu Chu, Minhui Li, Yantang Wang, Di Ding, Chunfen Mo, Huijie Guo, Yun Cao and Xiaoyan Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Brain Research.

In The Last Decade

Qiang Zou

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiang Zou China 21 763 365 228 221 122 56 1.2k
Yong Jae Shin South Korea 19 598 0.8× 202 0.6× 171 0.8× 218 1.0× 89 0.7× 31 1.1k
Haineng Xu China 17 560 0.7× 220 0.6× 238 1.0× 346 1.6× 87 0.7× 30 1.1k
Sharmistha Chakraborty United States 23 891 1.2× 211 0.6× 154 0.7× 303 1.4× 118 1.0× 41 1.4k
Sara Rezzola Italy 22 764 1.0× 207 0.6× 237 1.0× 128 0.6× 91 0.7× 42 1.5k
Hee Jun Cho South Korea 24 926 1.2× 267 0.7× 174 0.8× 386 1.7× 148 1.2× 53 1.4k
Yanhua Zheng China 13 1.2k 1.6× 633 1.7× 187 0.8× 231 1.0× 82 0.7× 29 1.7k
Yuyu Yang China 25 888 1.2× 235 0.6× 210 0.9× 168 0.8× 75 0.6× 45 1.3k

Countries citing papers authored by Qiang Zou

Since Specialization
Citations

This map shows the geographic impact of Qiang Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Zou more than expected).

Fields of papers citing papers by Qiang Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiang Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Zou. The network helps show where Qiang Zou may publish in the future.

Co-authorship network of co-authors of Qiang Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Qiang Zou. A scholar is included among the top collaborators of Qiang Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiang Zou. Qiang Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yiyi, et al.. (2023). A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis. Medicine. 102(19). e33739–e33739. 5 indexed citations
2.
Zou, Qiang, Meng Liu, Kewei Liu, et al.. (2023). E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities. Cellular Oncology. 46(3). 545–570. 19 indexed citations
3.
Li, Xiaoyan, ZhengMing Wu, Jing He, et al.. (2021). OGT regulated O-GlcNAcylation promotes papillary thyroid cancer malignancy via activating YAP. Oncogene. 40(30). 4859–4871. 46 indexed citations
4.
Ren, Kehan, Meili Wang, Ermin Li, et al.. (2021). RACGAP1 modulates ECT2-Dependent mitochondrial quality control to drive breast cancer metastasis. Experimental Cell Research. 400(1). 112493–112493. 41 indexed citations
5.
Cao, Yun, et al.. (2021). RNA-binding protein QKI suppresses breast cancer via RASA1/MAPK signaling pathway. Annals of Translational Medicine. 9(2). 104–104. 18 indexed citations
6.
Zhou, Yan, et al.. (2020). The p53 effector Perp mediates the persistence of CD4+ effector memory T-cell undergoing lymphopenia-induced proliferation. Immunology Letters. 224. 14–20. 3 indexed citations
7.
He, Jing, Mingxia Zhou, Xiaoyan Li, et al.. (2020). SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms. Oncogene. 39(13). 2658–2675. 38 indexed citations
8.
Yang, Liu, Chunyu Zhou, Pan Liu, et al.. (2020). Benzoxazole Derivative K313 Induces Cell Cycle Arrest, Apoptosis and Autophagy Blockage and Suppresses mTOR/p70S6K Pathway in Nalm-6 and Daudi Cells. Molecules. 25(4). 971–971. 3 indexed citations
9.
Chu, Chengyu, Hong Ren, Yun Cao, et al.. (2019). Prognostic value of epithelial-mesenchymal transition related genes: SLUG and QKI in breast cancer patients.. PubMed. 12(6). 2009–2021. 9 indexed citations
10.
Yu, Juan, Jigang Wang, Lei Zhang, et al.. (2016). MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin. Oncotarget. 7(25). 38612–38625. 48 indexed citations
11.
Wu, Fengjiao, Qiang Zou, Xiaodan Ding, et al.. (2016). Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain. Journal of Neuroinflammation. 13(1). 23–23. 89 indexed citations
12.
Chu, Chengyu, Yiting Jin, Wei Zhang, et al.. (2015). CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer. International Journal of Oncology. 48(1). 271–280. 34 indexed citations
13.
Liu, Yang, Hua Li, Jin Liu, et al.. (2015). A novel water-soluble benzothiazole derivative BD926 inhibits human activated T cell proliferation by down-regulating the STAT5 activation. European Journal of Pharmacology. 761. 36–43. 5 indexed citations
14.
Jin, Yiting, et al.. (2014). Association between molecular subtypes and lymph node status in invasive breast cancer.. PubMed. 7(10). 6800–6. 24 indexed citations
15.
Zhao, Min, Jin Huang, Qiang Zou, et al.. (2013). Expression and correlation of Twist and gelatinases in breast cancer. Experimental and Therapeutic Medicine. 6(1). 97–100. 23 indexed citations
16.
Wu, Zhenglong, et al.. (2013). The inhibitory role of Mir-29 in growth of breast cancer cells. Journal of Experimental & Clinical Cancer Research. 32(1). 98–98. 61 indexed citations
17.
Sui, Jiang-Dong, Hua Li, Yongfei Fang, et al.. (2011). NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in Han Chinese. Arthritis & Rheumatism. 64(3). 647–654. 71 indexed citations
18.
Zou, Qiang, et al.. (2009). Physostigmine-induced hypothermic response in rats and its relationship with endogenous arginine vasopressin. Life Sciences. 85(15-16). 586–591. 4 indexed citations
19.
20.
Zou, Qiang, Hongying Wang, Jian Zhou, et al.. (2007). Total parathyroidectomy combined with partial auto-transplantation for the treatment of secondary hyperparathyroidism. Chinese Medical Journal. 120(20). 1777–1782. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026